tradingkey.logo

Plus Therapeutics Announces Read Out Of Type B Meeting With The FDA

ReutersJan 8, 2026 12:57 PM

- Plus Therapeutics Inc PSTV.O:

  • PLUS THERAPEUTICS ANNOUNCES READ OUT OF TYPE B MEETING WITH THE FDA WITH GOAL OF ACCELERATING APPROVAL OF REYOBIQ™ FOR LEPTOMENINGEAL METASTASES

  • PLUS THERAPEUTICS INC - FDA INDICATES ACCELERATED APPROVAL MAY BE APPROPRIATE FOR LM

  • PLUS THERAPEUTICS INC - FDA RECOMMENDS STUDY EVALUATE ENDPOINT WITH CLINICAL BENEFIT

  • PLUS THERAPEUTICS INC - FDA CONVEYS MULTIPLE HISTOLOGIES MAY BE INCORPORATED IN TRIAL

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI